Beijing Chinese Medicine Clinic Inc Los Angeles, CA - 90010

Beijing Chinese Medicine Clinic Inc is categorized under Clinics in Los Angeles, CA and active since 2006.

Beijing Chinese Medicine Clinic Inc was established in 2006, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Kyu Ho Zeon at the company’s single location by writing to 3545 Wilshire Boulevard # 206, Los Angeles, California CA 90010 or by phoning (213) 389-3809. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Beijing Chinese Medicine Clinic Inc
Contact Person: Kyu Ho Zeon
Address: 3545 Wilshire Boulevard # 206, Los Angeles, California 90010
Phone Number: (213) 389-3809
Annual Revenue (USD): $50.000 to $99.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Beijing Chinese Medicine Clinic Inc was started in 2006 to provide professional Clinics under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Kyu Ho Zeon for inquiries that concern Beijing Chinese Medicine Clinic Inc by calling the company number (213) 389-3809, as your correspondence is most welcome. Additionally, the physical location of the single location of Beijing Chinese Medicine Clinic Inc can be found at the coordinates 34.061872,-118.30184 as well as the street address 3545 Wilshire Boulevard # 206 in Los Angeles, California 90010.

For its online presence, you may visit Beijing Chinese Medicine Clinic Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.